MX2018007326A - Composicion para reducir la frecuencia de miccion, metodo para elaborar y utilizar la misma. - Google Patents
Composicion para reducir la frecuencia de miccion, metodo para elaborar y utilizar la misma.Info
- Publication number
- MX2018007326A MX2018007326A MX2018007326A MX2018007326A MX2018007326A MX 2018007326 A MX2018007326 A MX 2018007326A MX 2018007326 A MX2018007326 A MX 2018007326A MX 2018007326 A MX2018007326 A MX 2018007326A MX 2018007326 A MX2018007326 A MX 2018007326A
- Authority
- MX
- Mexico
- Prior art keywords
- urination
- making
- composition
- reducing frequency
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
Se describen composiciones farmacéuticas para reducir la frecuencia de micción. Las composiciones farmacéuticas comprenden uno o más inhibidores de la via de prostaglandina y un portador farmacéuticamente aceptable. También se describen los métodos para elaborar y utilizar las composiciones farmacéuticas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/975,332 US10105328B2 (en) | 2014-06-06 | 2015-12-18 | Composition for reducing frequency of urination, method of making and use thereof |
PCT/US2016/065775 WO2017106032A1 (en) | 2015-12-18 | 2016-12-09 | Composition for reducing frequency of urination, method of making and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018007326A true MX2018007326A (es) | 2019-03-28 |
Family
ID=59057330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018007326A MX2018007326A (es) | 2015-12-18 | 2016-12-09 | Composicion para reducir la frecuencia de miccion, metodo para elaborar y utilizar la misma. |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP3389661A4 (es) |
JP (1) | JP2018538310A (es) |
KR (1) | KR20180101403A (es) |
CN (1) | CN108601782A (es) |
AU (1) | AU2016370313A1 (es) |
BR (1) | BR112018012030A2 (es) |
CA (1) | CA3008628A1 (es) |
IL (1) | IL259974A (es) |
MX (1) | MX2018007326A (es) |
RU (1) | RU2018126368A (es) |
SG (1) | SG11201806001TA (es) |
TW (1) | TW201726115A (es) |
WO (1) | WO2017106032A1 (es) |
ZA (1) | ZA201804749B (es) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5316772A (en) * | 1990-12-19 | 1994-05-31 | Solvay & Cie, S.A. (Societe Anonyme) | Bilayered oral pharmaceutical composition with pH dependent release |
GB201003734D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Delayed prolonged drug delivery |
TW201422254A (zh) * | 2012-11-21 | 2014-06-16 | Ferring Bv | 用於速釋及延釋的組成物 |
US20160074397A1 (en) * | 2013-03-13 | 2016-03-17 | Wellesley Pharmaceuticals, Llc | Composition for reducing frequency of urination, method of making and use thereof |
MX2016016039A (es) * | 2014-06-06 | 2017-08-24 | Wellesley Pharmaceuticals Llc | Formulacion farmaceutica para reducir la frecuencia de micción y método para su utilización.. |
WO2017058428A1 (en) * | 2015-09-30 | 2017-04-06 | Wellesley Pharmaceuticals, Llc | Composition for reducing the frequency of urination, method of making and use thereof |
-
2016
- 2016-12-09 EP EP16876420.7A patent/EP3389661A4/en not_active Withdrawn
- 2016-12-09 CA CA3008628A patent/CA3008628A1/en not_active Abandoned
- 2016-12-09 WO PCT/US2016/065775 patent/WO2017106032A1/en active Application Filing
- 2016-12-09 CN CN201680080714.5A patent/CN108601782A/zh active Pending
- 2016-12-09 BR BR112018012030A patent/BR112018012030A2/pt not_active Application Discontinuation
- 2016-12-09 MX MX2018007326A patent/MX2018007326A/es unknown
- 2016-12-09 SG SG11201806001TA patent/SG11201806001TA/en unknown
- 2016-12-09 RU RU2018126368A patent/RU2018126368A/ru not_active Application Discontinuation
- 2016-12-09 JP JP2018532044A patent/JP2018538310A/ja active Pending
- 2016-12-09 KR KR1020187020547A patent/KR20180101403A/ko unknown
- 2016-12-09 AU AU2016370313A patent/AU2016370313A1/en not_active Abandoned
- 2016-12-15 TW TW105141599A patent/TW201726115A/zh unknown
-
2018
- 2018-06-12 IL IL259974A patent/IL259974A/en unknown
- 2018-07-16 ZA ZA2018/04749A patent/ZA201804749B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20180101403A (ko) | 2018-09-12 |
WO2017106032A1 (en) | 2017-06-22 |
EP3389661A1 (en) | 2018-10-24 |
TW201726115A (zh) | 2017-08-01 |
BR112018012030A2 (pt) | 2018-12-04 |
ZA201804749B (en) | 2019-09-25 |
AU2016370313A1 (en) | 2018-07-26 |
SG11201806001TA (en) | 2018-08-30 |
JP2018538310A (ja) | 2018-12-27 |
CA3008628A1 (en) | 2017-06-22 |
EP3389661A4 (en) | 2019-12-18 |
CN108601782A (zh) | 2018-09-28 |
RU2018126368A (ru) | 2020-01-20 |
IL259974A (en) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20207074B (en) | New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them | |
GEP20207076B (en) | New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them | |
MA39986A (fr) | Dérivés de purine en tant qu'inhibiteurs de cd73 pour le traitement du cancer | |
GEP20207075B (en) | New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them | |
EP3592746A4 (en) | TYK2 INHIBITORS, THEIR USES AND THEIR PRODUCTION PROCESSES | |
AU2017435893B2 (en) | Methods for the administration of certain VMAT2 inhibitors | |
MX2016005297A (es) | Inhibidores del receptor del factor de crecimiento de fibroblastos. | |
PH12019501639A1 (en) | Jaki selective inhibitors | |
SG10201902326XA (en) | Mk2 inhibitors and uses thereof | |
MX2016015565A (es) | Ciertos inhibidores de la proteina quinasa. | |
MX2019000536A (es) | Nuevas pirimidinas carboxamidas como inhibidores de enzima vanina-1. | |
IL287902A (en) | Methods of administering certain vmat2 inhibitors | |
PH12017501816A1 (en) | Azabensimidazoles and their use as amp a receptor modulators | |
MX2017008386A (es) | Administración específica del sitio de un inhibidor de btk. | |
MX2020010116A (es) | Compuestos macrociclicos como inhibidores de quinasas del receptor de tropomiosina (trk). | |
MX2017013875A (es) | Ciertos inhibidores de la proteína quinasa. | |
MX2020007131A (es) | Inhibidores de histona acetiltransferasa de la familia myst. | |
PH12021550413A1 (en) | Vitamin d pediatric dosage forms, methods of making and using | |
MX2018005987A (es) | Compuestos heterociclicos para el tratamiento de enfermedades. | |
MX2020011756A (es) | Compuesto farmaceutico, sales del mismo, formulaciones del mismo y metodos para hacer y usar el mismo. | |
MX2016016039A (es) | Formulacion farmaceutica para reducir la frecuencia de micción y método para su utilización.. | |
WO2014145314A3 (en) | Methods and compositions for gamma-glutamyl cycle modulation | |
MA39877A (fr) | Formes solides d'un composé pharmaceutiquement actif | |
EP3665165A4 (en) | DHFR INHIBITORS, ASSOCIATED COMPOSITIONS AND PROCESSES | |
JOP20190163B1 (ar) | منشط nrf2 |